| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.0005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |